|
|
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2724-2732.
Prepublished online as a Blood First Edition Paper on December 14, 2004; DOI 10.1182/blood-2004-08-3037.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis
Joachim R. Göthert,
Sonja E. Gustin,
Mark A. Hall,
Anthony R. Green,
Berthold Göttgens,
David J. Izon, and
C. Glenn Begley
From the Division of Cancer Biology, Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, West Perth, Australia; Rotary Bone Marrow Research Laboratory, Royal Melbourne Hospital, Parkville, Victoria, Australia; and The University of Cambridge, Department of Haematology, Cambridge Institute for Medical Research, Cambridge, United Kingdom.
Evidence for the lineage relationship between embryonic and adult hematopoietic stem cells (HSCs) in the mouse is primarily indirect. In order to study this relationship in a direct manner, we expressed the tamoxifen-inducible Cre-ERT recombinase under the control of the stem cell leukemia (Scl) stem-cell enhancer in transgenic mice (HSC-SCL-Cre-ERT). To determine functionality, HSC-SCL-Cre-ERT transgenics were bred with Cre reporter mice. Flow cytometric and transplantation studies revealed tamoxifen-dependent recombination occurring in more than 90% of adult long-term HSCs, whereas the targeted proportion within mature progenitor populations was significantly lower. Moreover, the transgene was able to irreversibly tag embryonic HSCs on days 10 and 11 of gestation. These cells contributed to bone marrow hematopoiesis 5 months later. In order to investigate whether the de novo HSC generation is completed during embryogenesis, HSC-SCL-Cre-ERT–marked fetal liver cells were transplanted into adult recipients. Strikingly, the proportion of marked cells within the transplanted and the in vivo–remaining HSC compartment was not different, implying that no further HSC generation occurred during late fetal and neonatal stages of development. These data demonstrate for the first time the direct lineage relationship between midgestation embryonic and adult HSCs in the mouse. Additionally, the HSC-SCL-Cre-ERT mice will provide a valuable tool to achieve temporally controlled genetic manipulation of HSCs.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Creative stem cell assays
- Mervin C. Yoder
Blood 2005 105: 2622.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
S. L. Siggins, N.-Y N. Nguyen, M. P. McCormack, S. Vasudevan, R. Villani, S. M. Jane, B. J. Wainwright, and D. J. Curtis
The Hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cell-extrinsic mechanisms
Blood,
July 30, 2009;
114(5):
995 - 1004.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Smith, M.-J. Sanchez, G. A. Follows, S. Kinston, I. J. Donaldson, A. R. Green, and B. Gottgens
A novel mode of enhancer evolution: The Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity
Genome Res.,
September 1, 2008;
18(9):
1422 - 1432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yokomizo and E. Dzierzak
Fine-tuning of hematopoietic stem cell homeostasis: novel role for ubiquitin ligase
Genes & Dev.,
April 15, 2008;
22(8):
960 - 963.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Martinez-Agosto, H. K.A. Mikkola, V. Hartenstein, and U. Banerjee
The hematopoietic stem cell and its niche: a comparative view
Genes & Dev.,
December 1, 2007;
21(23):
3044 - 3060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Gothert, R. L. Brake, M. Smeets, U. Duhrsen, C. G. Begley, and D. J. Izon
NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis
Blood,
November 15, 2007;
110(10):
3753 - 3762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Mori, M. Itoi, N. Tsukamoto, H. Kubo, and T. Amagai
The perivascular space as a path of hematopoietic progenitor cells and mature T cells between the blood circulation and the thymic parenchyma
Int. Immunol.,
June 1, 2007;
19(6):
745 - 753.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Bowie, D. G. Kent, B. Dykstra, K. D. McKnight, L. McCaffrey, P. A. Hoodless, and C. J. Eaves
Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties
PNAS,
April 3, 2007;
104(14):
5878 - 5882.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. K. A. Mikkola and S. H. Orkin
The journey of developing hematopoietic stem cells.
Development,
October 1, 2006;
133(19):
3733 - 3744.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Pimanda, L. Silberstein, M. Dominici, B. Dekel, M. Bowen, S. Oldham, A. Kallianpur, S. J. Brandt, D. Tannahill, B. Gottgens, et al.
Transcriptional Link between Blood and Bone: the Stem Cell Leukemia Gene and Its +19 Stem Cell Enhancer Are Active in Bone Cells.
Mol. Cell. Biol.,
April 1, 2006;
26(7):
2615 - 2625.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
